Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Cash from Investing Activities: 2019-2023

Historic Cash from Investing Activities for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2023 value amounting to -$327,000.

  • ADC Therapeutics' Cash from Investing Activities rose 52.24% to -$327,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$3.2 million, marking a year-over-year decrease of 368.12%. This contributed to the annual value of -$867,000 for FY2024, which is 73.04% up from last year.
  • According to the latest figures from Q4 2023, ADC Therapeutics' Cash from Investing Activities is -$327,000, which was up 50.53% from -$661,000 recorded in Q3 2023.
  • Over the past 5 years, ADC Therapeutics' Cash from Investing Activities peaked at -$47 during Q3 2019, and registered a low of -$6.7 million during Q4 2021.
  • Over the past 3 years, ADC Therapeutics' median Cash from Investing Activities value was -$164,924 (recorded in 2021), while the average stood at -$881,333.
  • Per our database at Business Quant, ADC Therapeutics' Cash from Investing Activities skyrocketed by 99.87% in 2021 and then slumped by 260,136.22% in 2023.
  • Quarterly analysis of 5 years shows ADC Therapeutics' Cash from Investing Activities stood at -$2.2 million in 2019, then reached -$496,000 in 2020, then spiked by 99.87% to -$6.7 million in 2021, then soared by 89.73% to -$684,609 in 2022, then skyrocketed by 52.24% to -$327,000 in 2023.
  • Its Cash from Investing Activities stands at -$327,000 for Q4 2023, versus -$661,000 for Q3 2023 and -$1.2 million for Q2 2023.